Trial NCT03100877

View at ClinicalTrials.gov 
Org. Study IDs: 16464
Secondary IDs: 16464 NCI-2017-00512

Last trial update was posted on 2017-12-13

MeSH Interventions

Cyclophosphamide Lenalidomide Lenograstim Mechlorethamine Melphalan Mitogens Nitrogen Mustard Compounds

MeSH Conditions

Leukemia, Plasma Cell Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions

Plasma Cell Leukemia in Remission Plasma Cell Myeloma

Stopping Reasons

Feasibility Issues

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID